Top Analyst Upgrades and Downgrades: Allscripts, AmeriGas, CVS, IMAX, Kraft Heinz, Marathon Oil, Microsoft, Pfizer and Many More
Stocks were indicated to open higher by over 100 more points on the Dow Jones industrial average and 13 points on the S&P 500 on additional China-trade developments as tariff deadlines were extended as talks are proceeding positively. Now that the Dow has risen over 3,000 points from its lows of early January, investors need to be considering how they want their assets positioned for 2019 and beyond.
24/7 Wall St. reviews dozens of analyst research reports each day of the week in an effort to find new ideas for investors and traders alike. Some of these analyst reports cover stocks to buy, while others cover stocks to sell or to avoid.
Additional commentary has been added on most of the daily analyst reports, along with trading history. The consensus analyst price targets and other valuation metrics are from the Thomson Reuters sell-side research service.
These were the top analyst upgrades, downgrades and initiations seen for Monday, February 25, 2019.
Allegion PLC (NYSE: ALLE) was downgraded to In-Line from Outperform but the price target was raised to $96 from $94 at Imperial Capital.
Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) was downgraded to Neutral from Buy and the price target was lowered to $12 from $14 (versus a $10.60 prior close, after an 11.2% drop) at Citigroup.
AmeriGas Partners L.P. (NYSE: APU) was raised to Neutral from Sell and the price target was raised to $31 from $24 (versus a $29.60 close) at UBS. It has a 12% yield-equivalent distribution.
Antares Pharma Inc. (NASDAQ: ATRS) was started as Outperform and assigned a $7 price target (versus a $3.28 close) at Cowen. The stock was indicated up 2.5% at $3.30, in a 52-week range of $1.99 to $3.99 and with a $507 million market cap.
Apartment Investment and Management Co. (NYSE: AIV) was downgraded to Hold from Buy at SunTrust Robinson Humphrey.
Beacon Roofing Supply Inc. (NASDAQ: BECN) was started as Neutral at Buckingham Research.
BMC Stock Holdings Inc. (NASDAQ: BMCH) was started as Neutral at Buckingham Research.
Brunswick Corp. (NYSE: BC) was raised to Overweight from Neutral at JPMorgan.
Builders FirstSource Inc. (NASDAQ: BLDR) was started as Neutral at Buckingham Research.
Capstead Mortgage Corp. (NYSE: CMO) was raised to Market Perform from Underperform and the target price was raised to $8.50 from $7.00 (versus an $8.23 close) at Keefe Bruyette & Woods.
Cboe Global Markets Inc. (BATS: CBOE) was raised to Overweight from Neutral at MKM Partners.
CVS Health Corp. (NYSE: CVS) was maintained as Buy at Argus, but the independent research firm lowered its target price to $80 from $100. Shares closed at $61.95 ahead of the call, but Argus sees the challenging industry dynamics reinforcing its belief that CVS is better positioned with Aetna than without it.
CyrusOne Inc. (NASDAQ: CONE) was downgraded to Neutral from Outperform and the price target was lowered to $52 from $68 (versus a $52.87 close) at Credit Suisse.
Diplomat Pharmacy Inc. (NASDAQ: DPLO) was downgraded to Neutral from Overweight and the price target was cut to $9 at JPMorgan. Shares were down 56% at $5.87 on Friday on news that it was withdrawing its 2019 outlook and delaying its 2018 annual report after earnings.
Eversource Energy (NYSE: ES) was downgraded to Underperform from Neutral with a $68 price objective (versus a $70.30 close) at Merrill Lynch.
Foot Locker Inc. (NYSE: FL) was reiterated as Outperform and the price target was raised to $70 from $63 at Credit Suisse. Wedbush also reiterated its Outperform rating and raised its target to $67 from $63 with above-consensus FY19 estimates heading into results on March 1. The stock was indicated up 2.2% at $61.00 on Monday.